Metabolically Activated Adipose Tissue Macrophages Perform Detrimental and Beneficial Functions during Diet-Induced

Brittney R Coats1, Kelly Q Schoenfelt2, Valéria C Barbosa-Lorenzi3

  • 1Committee on Molecular Metabolism and Nutrition, The University of Chicago, Chicago, IL 60637, USA.

Cell Reports
|September 28, 2017
PubMed

Insights

Metabolically activated macrophages in obesity clear dead fat cells via lysosomal exocytosis. The enzyme NADPH oxidase 2 (NOX2) drives this process, but its absence worsens obesity-related metabolic dysfunction over time.

Area of Science:

  • Immunology
  • Metabolic Diseases
  • Cell Biology

Background:

  • Obesity leads to adipose tissue macrophages (ATMs) adopting a metabolically activated (MMe) phenotype.
  • The precise functions of MMe macrophages in obesity are not fully understood.

Purpose of the Study:

  • To investigate the functions of MMe macrophages in obesity.
  • To identify key molecular drivers of MMe macrophage functions.
  • To determine the role of NADPH oxidase 2 (NOX2) in obesity-related metabolic changes.

Main Methods:

  • Proteomic and functional analyses of ATMs.
  • Studies using wild-type and Nox2 knockout (Nox2-/-) mice fed a high-fat diet.
  • Assessment of metabolic parameters, inflammation, and adipocyte clearance.

Main Results:

  • MMe macrophages clear dead adipocytes via lysosomal exocytosis and potentiate inflammation.
  • NADPH oxidase 2 (NOX2) drives both the inflammatory and adipocyte-clearing functions of MMe macrophages.
  • Nox2-/- mice show improved glucose tolerance early in diet-induced obesity but develop severe insulin resistance, hepatosteatosis, and lipoatrophy later, with impaired dead adipocyte clearance.

Conclusions:

  • MMe macrophages have dual roles in obesity, promoting inflammation and clearing dead adipocytes.
  • NOX2 is crucial for MMe macrophage functions, with its absence leading to detrimental metabolic outcomes as obesity progresses.
  • The contribution of MMe macrophage functions to metabolic phenotypes is dependent on the stage of obesity.

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
5.9K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
226